Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19-Reference-Cited by-同舟云学术

Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19

Published:2021-04-20 Issue:15 Volume:325 Page:1535
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Stephenson Kathryn E.¹²³,Le Gars Mathieu⁴,Sadoff Jerald⁴,de Groot Anne Marit⁴,Heerwegh Dirk⁵,Truyers Carla⁵,Atyeo Caroline²⁶,Loos Carolin²⁷,Chandrashekar Abishek¹,McMahan Katherine¹,Tostanoski Lisa H.¹,Yu Jingyou¹,Gebre Makda S.¹⁶,Jacob-Dolan Catherine¹⁶,Li Zhenfeng¹,Patel Shivani¹,Peter Lauren¹,Liu Jinyan¹,Borducchi Erica N.¹,Nkolola Joseph P.¹,Souza Morgana¹,Tan Chen Sabrina¹³,Zash Rebecca¹³,Julg Boris¹²,Nathavitharana Ruvandhi R.³,Shapiro Roger L.³,Azim Ahmed Abdul³,Alonso Carolyn D.³,Jaegle Kate¹,Ansel Jessica L.¹,Kanjilal Diane G.¹,Guiney Caitlin J.¹,Bradshaw Connor¹,Tyler Anna¹,Makoni Tatenda¹,Yanosick Katherine E.¹,Seaman Michael S.¹,Lauffenburger Douglas A.⁷,Alter Galit²,Struyf Frank⁵,Douoguih Macaya⁴,Van Hoof Johan⁴,Schuitemaker Hanneke⁴,Barouch Dan H.¹²³⁶⁸

Affiliation:

1. Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts

2. Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts

3. Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts

4. Janssen Vaccines & Prevention, Leiden, the Netherlands

5. Janssen Research & Development, Beerse, Belgium

6. Harvard Medical School, Boston, Massachusetts

7. Massachusetts Institute of Technology, Cambridge

8. Massachusetts Consortium on Pathogen Readiness, Boston

Publisher

American Medical Association (AMA)

Subject